Kidney Organoids: Disease Modeling and Clinical Implementations for Patient Benefit
Nephron · 12.06.2026 · 1-14
DOI: 10.1159/000553059 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nephron, online erschienen am 12.06.2026. Verfasst von Elisa Gessaroli und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Illinois Chicago, Chicago, Illinois, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 95 Literaturangaben.
Abstract (Originalsprache)
Background: Progress in nephrology is still constrained by the limited ability of conventional experimental models to faithfully recapitulate the complex structure and function of the human kidney. Human pluripotent stem cell-derived kidney organoids provide a three-dimensional in vitro experimental system that allows investigation of kidney development and disease-related mechanisms in a human cellular context, although still limited in their ability to reproduce the full structural and physiological complexity of the native kidney. Summary: Kidney organoids have emerged as a powerful system to investigate both inherited and acquired kidney disorders. Genetic applications include cystic kidney diseases and ciliopathies, as well as inherited tubular and storage disorders, and glomerular genetic diseases. For acquired diseases and injuries, organoids support modeling of kidney damage (including exposure to pathogenetic factors, metabolic, diabetic, and profibrotic stress) and drug nephrotoxicity. These platforms enable research on mechanistic pathways through transcriptomic, proteomic, imaging, and functional readouts that can be applied at the level of specific nephron segments. Methodological advances, including improved differentiation protocols and organoid-on-chip systems, are enhancing maturation and physiological relevance. Nevertheless, kidney organoids remain immature, showing variable cellular composition and lacking a fully integrated vasculature and urinary outflow system, which currently limit their applicability as experimental models. Key Messages: Kidney organoids provide a human-based platform for mechanistic and translational nephrology research. At present, kidney organoids are mainly used for disease modeling and nephrotoxicity testing, while their broader applicability remains limited by current technical and biological challenges. Regenerative translation will depend on advances in maturation and integration of fully developed vascular and urinary system components.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, University of Illinois Chicago, Chicago, Illinois, USA.
- Department of Medical and Surgical Sciences (DIMEC), Alma Mater Studiorum - University of Bologna, Bologna, Italy.
- Southern Arizona VA Healthcare System, Tucson, Arizona, USA.
- Department of Surgery, University of Arizona College of Medicine, Tucson, Arizona, USA.
- Department of Surgery, University of Arizona College of Medicine, Tucson, Arizona, USA, akgupta@surgery.arizona.edu.
- Department of Medicine, University of Illinois Chicago, Chicago, Illinois, USA, lgallon@uic.edu.
Zitieren
APA
Gessaroli, E., Donini, S., Wertheim, J. A., Gupta, A. K., & Gallon, L. (2026). Kidney Organoids: Disease Modeling and Clinical Implementations for Patient Benefit. Nephron, 1-14. https://doi.org/10.1159/000553059
Vancouver
Gessaroli E, Donini S, Wertheim JA, Gupta AK, Gallon L. Kidney Organoids: Disease Modeling and Clinical Implementations for Patient Benefit. Nephron. 2026:1-14. doi:10.1159/000553059
BibTeX
@article{Gessaroli2026,
author = {Gessaroli, Elisa and Donini, Sara and Wertheim, Jason A and Gupta, Ashwani Kumar and Gallon, Lorenzo},
title = {Kidney Organoids: Disease Modeling and Clinical Implementations for Patient Benefit},
journal = {Nephron},
year = {2026},
pages = {1--14},
doi = {10.1159/000553059}
}
EUVIMED